Ilona Fitos
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ilona Fitos has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
- Ferenc Zsila
Budakeszi Hungary
4 shared publications Júlia Visy
Department of Molecular Pharmacology, Institute of Biomolecular Chemistry, Chemical Research Center, Hungarian Academy of Sciences, Budapest, POB 17, H-1525, Hungary
4 shared publicationsGyörgy Mády
Department of Molecular Pharmacology, Institute of Biomolecular Chemistry, Chemical Research Center, Hungarian Academy of Sciences, Budapest, POB 17, H-1525, Hungary
3 shared publicationsMiklós Simonyi
Department of Molecular Pharmacology, Institute of Biomolecular Chemistry, Chemical Research Center, Hungarian Academy of Sciences, Budapest, POB 17, H-1525, Hungary
3 shared publicationsG. Kéri
1 shared publicationG. Mády
1 shared publication
Latest Publications
- 1 April 2012
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 50 (3) , 788-795
Characterization of binding mode of imatinib to human α1-acid glycoprotein
- 1 April 2012
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 50 (3) , 788-795
Characterization of binding mode of imatinib to human α1-acid glycoprotein
- 28 August 2009
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - General Subjects
- Vol. 1800 (3) , 367-372
Selective binding interactions of deramciclane to the genetic variants of human α1-acid glycoprotein
- 28 August 2009
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - General Subjects
- Vol. 1800 (3) , 367-372
Selective binding interactions of deramciclane to the genetic variants of human α1-acid glycoprotein
- 1 July 2007
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 15 (14) , 4857-4862
Conformation selectivity in the binding of diazepam and analogues to α1-acid glycoprotein
- 1 July 2007
- Published by Elsevier in Bioorganic & Medicinal Chemistry
- Vol. 15 (14) , 4857-4862
Conformation selectivity in the binding of diazepam and analogues to α1-acid glycoprotein
- 1 November 2006
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - General Subjects
- Vol. 1760 (11) , 1704-1712
Selective binding of imatinib to the genetic variants of human α1-acid glycoprotein
- 1 November 2006
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - General Subjects
- Vol. 1760 (11) , 1704-1712
Selective binding of imatinib to the genetic variants of human α1-acid glycoprotein
- 1 December 2002
- Published by Elsevier in Journal of Biochemical and Biophysical Methods
- Vol. 54 (1-3) , 71-84
Species-dependency in chiral-drug recognition of serum albumin studied by chromatographic methods
- 1 December 2002
- Published by Elsevier in Journal of Biochemical and Biophysical Methods
- Vol. 54 (1-3) , 71-84
Species-dependency in chiral-drug recognition of serum albumin studied by chromatographic methods
Stereoselective kinetics of warfarin binding to human serum albumin: Effect of an allosteric interaction
Kinetic and equilibrium binding studies were performed on the interaction of warfarin enantiomers with human serum albumin (HSA) in the absence and presence of lorazepam acetate (LoAc) enantiomers. Binding kinetics were followed by recording changes in the fluorescence of warfarin upon binding to HSA using the stopped‐flow technique. The binding of (R)‐warfarin displayed an exponentially increasing fluorescence, satisfying the two‐step mechanism reported previously for the racemate, i.e., a diffusion controlled pre‐equilibrium is followed by a slower rearrangement of the complex. In the case of (S)‐warfarin, the signal was biphasic: a fast fluorescence enhancement was followed by a slow decline. The different kinetic features indicate that the equilibrium conformations of the [(S)‐warfarin‐HSA] and [(R)‐warfarin‐HSA] complexes are achieved via different mechanisms. The phenomenon was seen in buffers of different pH and compositions. Equilibrium binding measurements indicated significantly lower molar intrinsic fluorescence for the (S)‐warfarin complex, suggesting differences in the microenvironments of the bound enantiomers. In the presence of (S)‐LoAc, the allosterically enhanced binding of (S)‐warfarin manifested itself in accelerated relaxation kinetics. In accordance with the low molar intrinsic fluorescence determined for the stable ternary complex, the amplitude of the decline in fluorescence became larger. Chirality 14:442–448, 2002.
Stereoselective kinetics of warfarin binding to human serum albumin: Effect of an allosteric interaction
Kinetic and equilibrium binding studies were performed on the interaction of warfarin enantiomers with human serum albumin (HSA) in the absence and presence of lorazepam acetate (LoAc) enantiomers. Binding kinetics were followed by recording changes in the fluorescence of warfarin upon binding to HSA using the stopped‐flow technique. The binding of (R)‐warfarin displayed an exponentially increasing fluorescence, satisfying the two‐step mechanism reported previously for the racemate, i.e., a diffusion controlled pre‐equilibrium is followed by a slower rearrangement of the complex. In the case of (S)‐warfarin, the signal was biphasic: a fast fluorescence enhancement was followed by a slow decline. The different kinetic features indicate that the equilibrium conformations of the [(S)‐warfarin‐HSA] and [(R)‐warfarin‐HSA] complexes are achieved via different mechanisms. The phenomenon was seen in buffers of different pH and compositions. Equilibrium binding measurements indicated significantly lower molar intrinsic fluorescence for the (S)‐warfarin complex, suggesting differences in the microenvironments of the bound enantiomers. In the presence of (S)‐LoAc, the allosterically enhanced binding of (S)‐warfarin manifested itself in accelerated relaxation kinetics. In accordance with the low molar intrinsic fluorescence determined for the stable ternary complex, the amplitude of the decline in fluorescence became larger. Chirality 14:442–448, 2002.